[1]白子超,李雁杰,曹荣霞,等.糖尿病视网膜病变诊疗的研究现状:基于OCTA[J].眼科新进展,2021,41(9):887-891.[doi:10.13389/j.cnki.rao.2021.0186]
　BAI Zichao,LI Yanjie,CAO Rongxia,et al.Optical coherence tomography angiography in the progress of diabetic retinopathy[J].Recent Advances in Ophthalmology,2021,41(9):887-891.[doi:10.13389/j.cnki.rao.2021.0186]
点击复制

糖尿病视网膜病变诊疗的研究现状:基于OCTA/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
41卷
期数:
2021年9期
页码:
887-891
栏目:
文献综述
出版日期:
2021-09-05

文章信息/Info

Title:
Optical coherence tomography angiography in the progress of diabetic retinopathy
作者:
白子超; 李雁杰; 曹荣霞; 李鲜; 杨柳森; 张转转; 吕超然
030000　山西省太原市，山西医科大学第一医院眼科
Author(s):
BAI Zichao; LI Yanjie; CAO Rongxia; LI Xian; YANG Liusen; ZHANG Zhuanzhuan; L Chaoran
Department of Ophthalmology,the First Hospital of Shanxi Medical University, Taiyuan 030000,Shanxi Province,China
关键词:
光学相干断层扫描血管造影术; 糖尿病视网膜病变; 血管密度; 黄斑中央凹无血管区; 糖尿病性黄斑水肿
Keywords:
optical coherence tomography angiography;  diabetic retinopathy;  vessel density;  foveal avascular zone;  diabetic macular edema
分类号:
R774.1
DOI:
10.13389/j.cnki.rao.2021.0186
文献标志码:
A
摘要:
糖尿病是一种由高血糖引起的慢性进行性疾病，糖尿病视网膜病变（DR）作为其常见的微血管损伤并发症，可以造成视力损伤甚至失明，是引起中老年人群致盲的主要原因之一。OCTA是一种无创、快速和高效的成像技术，可用于检测视网膜微血管的变化，尤其可以清晰地显示糖尿病黄斑病变。因此，其可用于监测DR的病情变化，并可用于判断患者预后。本文将对OCTA 在DR诊疗中的应用作一综述。
Abstract:
Diabetes mellitus is a chronic progressive disease caused by hyperglycemia. Diabetic retinopathy (DR), as a common diabetic complication of microvascular injury, can cause visual impairment and even blindness, which is one of the main causes of blindness in the elderly. Optical coherence tomography angiography (OCTA) is a noninvasive, rapid and efficient imaging technique to detect retinal microvascular changes, which clearly visualizes diabetic macular lesions. Therefore, it can be used to monitor the disease changes of DR and help determine the prognosis. This study aims to review the application of OCTA in the diagnosis and treatment of DR.

参考文献/References:

［1］　YAU J W,ROGERS S L,KAWASAKI R,LAMOUREUX E L,KOWALSKI J W,BEK T,et al.Global prevalence and major risk factors of diabetic retinopathy［J］.Diabetes Care,2012,35(3):556-564.
［2］　张凤俊，李晶明，刘秋平.糖尿病视网膜病变发病机制及潜在治疗研究进展［J］.眼科新进展，2020，40(7)：677-685.
ZHANG F J，LI J M，LIU Q P.Research progress on pathogenesis and potential treatment of diabetic retinopathy［J］.Rec Adv Ophthalmol，2020，40(7)：677-685.
［3］　WANG W,LO A C Y.Diabetic retinopathy:pathophysiology and treatments［J］.Int J Mol Sci,2018,19(6):1816.
［4］　ROMERO-AROCA P,BAGET-BERNALDIZ M,PAREJA-RIOS A,LOPEZ-GALVEZ M,NAVARRO-GIL R,VERGES R.Diabetic macular edema pathophysiology:vasogenic versus inflammatory［J］.J Diabetes Res,2016,2016:2156273.
［5］　WANG S,ZUO Y,WANG N,TONG B.Fundus fluorescence angiography in diagnosing diabetic retinopathy［J］.Pak J Med Sci,2017,33(6):1328-1332.
［6］　TLU,CLUGRU D M,LUPA CU C A.Characterisation of human non-proliferative diabetic retinopathy using the fractal analysis［J］.Int J Ophthalmol,2015,8(4):770-776.
［7］　COSCAS G,LUPIDI M,COSCAS F.Image analysis of optical coherence tomography angiography［J］.Dev Ophthalmol,2016,56:30-36.
［8］　SPAIDE R F,KLANCNIK J M Jr,COONEY M J.Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography［J］.JAMA Ophthalmol,2015,133(1):45-50.
［9］　SALZ D A,DE CARLO T E,ADHI M,MOULT E,CHOI W,BAUMAL C R,et al.Select features of diabetic retinopathy on swept-source optical coherence tomographic angiography compared with fluorescein angiography and normal eyes［J］.JAMA Ophthalmol,2016,134(6):644-650.
［10］　MARMOR M F,RAVIN J G.Fluorescein angiography:insight and serendipity a half century ago［J］.Arch Ophthalmol,2011,129(7):943-948.
［11］　MATSUNAGA D,YI J,PULIAFITO C A,KASHANI A H.OCT angiography in healthy human subjects［J］.Ophthalmic Surg Lasers Imaging Retina,2014,45(6):510-515.
［12］　PARK J J,SOETIKNO B T,FAWZI A A.Characterization of the middle capillary plexus using optical coherence tomography angiography in healthy and diabetic eyes［J］.Retina,2016,36(11):2039-2050.
［13］　ZAHID S,DOLZ-MARCO R,FREUND K B,BALARATNASINGAM C,DANSINGANI K,GILANI F,et al.Fractal dimensional analysis of optical coherence tomography angiography in eyes with diabetic retinopathy［J］.Invest Ophthalmol Vis Sci,2016,57(11):4940-4947.
［14］　CHU Z,LIN J,GAO C,XIN C,ZHANG Q,CHEN C L,et al.Quantitative assessment of the retinal microvasculature using optical coherence tomography angiography［J］.J Biomed Opt,2016,21(6):66008.
［15］　ISHIBAZAWA A,NAGAOKA T,TAKAHASHI A,OMAE T,TANI T,SOGAWA K,et al.Optical coherence tomography angiography in diabetic retinopathy:a prospective pilot study［J］.Am J Ophthalmol,2015,160(1):35-44.
［16］　KIM A Y,CHU Z,SHAHIDZADEH A,WANG R K,PULIAFITO C A,KASHANI A H.Quantifying microvascular density and morphology in diabetic retinopathy using spectral-domain optical coherence tomography angiography［J］.Invest Ophthalmol Vis Sci,2016,57(9):362-370.
［17］　CHOI W,WAHEED N K,MOULT E M,ADHI M,LEE B,DE CARLO T,et al.Ultrahigh speed swept source optical coherence tomography angiography of retinal and choriocapillaris alterations in diabetic patients with and without retinopathy［J］.Retina,2017,37(1):11-21.
［18］　刘青，艾明.光学相干断层扫描血管成像(OCTA)和荧光素血管造影(FFA)对比增生型糖尿病视网膜病变（PDR）［J］.眼科新进展，2017，37（1）：52-55.
LIU Q，AI M.Comparison of optical coherence tomography angiography (OCTA) and fluorescein angiography (FFA) in proliferative diabetic retinopathy (PDR)［J］.Rec Adv Ophthalmol,2017,37(1)：52-55.
［19］　TAN B,CHUA J,LIN E,CHENG J,GAN A,YAO X,et al.Quantitative microvascular analysis with wide-field optical coherence tomography angiography in eyes with diabetic retinopathy［J］.JAMA Netw Open,2020,3(1):e1919469.
［20］　ZHENG Y,GANDHI J S,STANGOS A N,CAMPA C,BROADBENT D M,HARDING S P.Automated segmentation of foveal avascular zone in fundus fluorescein angiography［J］.Invest Ophthalmol Vis Sci,2010,51(7):3653-3659.
［21］　DELAEY C,VAN DE VOORDE J.Regulatory mechanisms in the retinal and choroidal circulation［J］.Ophthalmic Res,2000,32(6):249-256.
［22］　GONG D,YU W h,ZHANG X,YANG Z K,ZOU X,QU Y,et al.A morphological study of the foveal avascular zone in patients with diabetes mellitus using optical coherence tomography angiography［J］.Graefes Arch Clin Exp Ophthalmol,2016,254(5):873-879.
［23］　BALARATNASINGAM C,INOUE M,AHN S,MCCANN J,DHRAMI-GAVAZI E,YANNUZZI L A,et al.Visual acuity is correlated with the area of the foveal avascular zone in diabetic retinopathy and retinal vein occlusion［J］.Ophthalmology,2016,123(11):2352-2367.
［24］　DALAN D,NANDINI P,ANGAYARKANNI N,KAVIARASAN K,THANIKACHALAM S,DAS UN,et al.Interchangeability of retinal perfusion indices in different-sized angiocubes:an optical coherence tomography angiography study in diabetic retinopathy［J］.Indian J Ophthalmol,2020,68(3):484-489.
［25］　YU P K,BALARATNASINGAM C,CRINGLE S J,MCALLISTER I L,PROVIS J,YU D Y.Microstructure and network organization of the microvasculature in the human macula［J］.Invest Ophthalmol Vis Sci,2010,51(12):6735-6743.
［26］　BEK T.Regional morphology and pathophysiology of retinal vascular disease［J］.Prog Retin Eye Res,2013,36:247-259.
［27］　SHEN C,YAN S,DU M,ZHAO H,SHAO L,HU Y.Assessment of capillary dropout in the superficial retinal capillary plexus by optical coherence tomography angiography in the early stage of diabetic retinopathy［J］.BMC Ophthalmol,2018,18(1):113.
［28］　NESPER P L,ROBERTS P K,ONISHI A C,CHAI H,LIU L,JAMPOL L M,et al.Quantifying microvascular abnormalities with increasing severity of diabetic retinopathy using optical coherence tomography angiography［J］.Invest Ophthalmol Vis Sci,2017,58(6):307-315.
［29］　SAMARA W A,SHAHLAEE A,ADAM M K,KHAN M A,CHIANG A,MAGUIRE J I,et al.Quantification of diabetic macular ischemia using optical coherence tomography angiography and its relationship with visual acuity［J］.Ophthalmology,2017,124(2):235-244.
［30］　ALAM M,ZHANG Y,LIM J I,CHAN R V P,YANG M,YAO X.Quantitative optical coherence tomography angiography features for objective classification and staging of diabetic retinopathy［J］.Retina,2020,40(2):322-332.
［31］　TANG F Y,CHAN E O,SUN Z,WONG R,LOK J,SZETO S,et al.Clinically relevant factors associated with quantitative optical coherence tomography angiography metrics in deep capillary plexus in patients with diabetes［J］.Eye Vis (Lond),2020,7:7.
［32］　VAN DIJK H W,VERBRAAK F D,KOK P H,STEHOUWER M,GARVIN M K,SONKA M,et al.Early neurodegeneration in the retina of type 2 diabetic patients［J］.Invest Ophthalmol Vis Sci,2012,53(6):2715-2719.
［33］　SUGIMOTO M,SASOH M,IDO M,WAKITANI Y,TAKAHASHI C,UJI Y.Detection of early diabetic change with optical coherence tomography in type 2 diabetes mellitus patients without retinopathy［J］.Ophthalmologica,2005,219(6):379-385.
［34］　LIU L,WANG Y,LIU H X,GAO J.Peripapillary region perfusion and retinal nerve fiber layer thickness abnormalities in diabetic retinopathy assessed by OCT angiography［J］.Transl Vis Sci Technol,2019,8(4):14.
［35］　YU P K,CRINGLE S J,YU D Y.Correlation between the radial peripapillary capillaries and the retinal nerve fibre layer in the normal human retina［J］.Exp Eye Res,2014,129:83-92.
［36］　CHEN C L,BOJIKIAN K D,XIN C,WEN J C,GUPTA D,ZHANG Q,et al.Repeatability and reproducibility of optic nerve head perfusion measurements using optical coherence tomography angiography［J］.J Biomed Op,2016,21(6):65002.
［37］　BAZVAND F,MIRSHAHI R,FADAKAR K,FAGHIHI H,SABOUR S,GHASSEMI F.The quantitative measurements of vascular density and flow area of optic nerve head using optical coherence tomography angiography［J］.J Glaucoma,2017,26(8):735-741.
［38］　HUANG J,ZHENG B,LU Y,GU X,DAI H,CHEN T.Quantification of microvascular density of the optic nerve head in diabetic retinopathy using optical coherence tomographic angiography［J］.J Ophthalmol,2020,2020:5014035.
［39］　GILL A,COLE E D,NOVAIS E A,LOUZADA R N,DE CARLO T,DUKER J S,et al.Visualization of changes in the foveal avascular zone in both observed and treated diabetic macular edema using optical coherence tomography angiography［J］.Int J Retina Vitreous,2017,3:19.
［40］　MOEIN H R,NOVAIS E A,REBHUN C B,COLE E D,LOUZADA R N,WITKIN A J,et al.Optical coherence tomography angiography to detect macular capillary ischemia in patients with inner retinal changes after resolved diabetic macular edema［J］.Retina,2018,38(12):2277-2284.
［41］　HSIEH Y T,ALAM M N,LE D,HSIAO C C,YANG C H,CHAO D L,et al.OCT Angiography biomarkers for predicting visual outcomes after ranibizumab treatment for diabetic macular edema［J］.Ophthalmol Retina,2019,3(10):826-834.
［42］　MATSUNAGA D R,YI J J,DE KOO L O,AMERI H,PULIAFITO C A,KASHANI A H.Optical coherence tomography angiography of diabetic retinopathy in human subjects［J］.Ophthalmic Surg Lasers Imaging Retina,2015,46(8):796-805.
［43］　SPAIDE R F,FUJIMOTO J G,WAHEED N K,SADDA S R,STAURENGHI G.Optical coherence tomography angiography［J］.Prog Retin Eye Res,2018,64:1-55.

相似文献/References:

[1]杜玮 刘子扬 周艳艳 雒雷鸣.糖尿病视网膜病变与血清胆红素水平的关系[J].眼科新进展,2012,32(5):000.
[2]范松涛 卢建民.阿司匹林与糖尿病患者玻璃体出血以及玻璃体切割术疗效的相关性研究[J].眼科新进展,2012,32(11):000.
[3]李艳 李筱荣 袁佳琴 潘斌.糖尿病大鼠视网膜中VEGF、PEDF的表达与血-视网膜屏障损伤[J].眼科新进展,2013,33(1):000.
[4]李朝晖 崔治华 胡晓英 孟丽珠 张敬维.糖尿病视网膜病变激光面积与疗效的分析[J].眼科新进展,2013,33(2):000.
[5]冯冬梅 朱鸿 施彩虹.CXC趋化因子及其受体在糖尿病视网膜病变中的作用[J].眼科新进展,2013,33(6):000.
[6]牛淑玲.糖尿病视网膜病变患者HbAlc、FPG与血小板参数的变化及危险因素分析[J].眼科新进展,2013,33(7):000.
[7]毕春潮 王睿 王建洲 雷春灵 董晓娟 王小莉 薛晓辉.Ad-PEDF对糖尿病视网膜病变大鼠视网膜新生血管的抑制作用[J].眼科新进展,2013,33(8):000.
[8]杨萍 孙书明 李晓鹏.辛伐他汀对糖尿病视网膜病变和炎症因子的影响[J].眼科新进展,2013,33(8):000.
[9]罗文婷 孙大卫.血管黏附蛋白-1在眼科疾病中的研究进展[J].眼科新进展,2013,33(8):000.
[10]李小璐 马雅玲.糖尿病视网膜病变大鼠视网膜VEGF和PEDF的动态表达[J].眼科新进展,2013,33(9):000.

备注/Memo

备注/Memo:
山西省科技厅重点研发计划项目（编号:201803D31095）；山西省人力资源与社会保障厅2019年省留学人员科技活动项目（编号：2019-91-4）
更新日期/Last Update: 2021-09-05